← Medication Database
Neurology

Aimovig

Generic: erenumab

Manufacturer: Amgen / Novartis  ·  Program: Amgen Safety Net Foundation

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Must be uninsured or underinsured (insurance does not cover the drug). Medicare Part D patients may be eligible if they meet specific financial criteria and are unable to afford their medication.

Residency

U.S. resident or resident of U.S. territories with a valid address

Income Threshold

Up to 500% FPL

Individual Income Limit

$75,300/year

Calculated based on 500% FPL, which is the standard threshold for the Amgen Safety Net Foundation for Aimovig.

Program Information

Processing Time

7-10 business days

Delivery Method

shipped to patient

Application Method

Multiple

Reauthorization

Required — annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • Completed application form with physician signature
  • Proof of income (e.g., most recent tax return, W-2, or pay stubs)
  • Valid prescription

Indicated For

Preventive treatment of migraine in adults

About This Medication

# Getting Aimovig (Erenumab) for Free or Reduced Cost Through the Amgen Safety Net Foundation ## Who Qualifies for the Amgen Safety Net Foundation? If you need Aimovig (erenumab) for migraine prevention but cannot afford it, the **Amgen Safety Net Foundation** may be able to provide it at no cost to you. This program is designed for patients who are uninsured or whose insurance does not cover Aimovig. To qualify, you generally need to meet income guidelines — for a single-person household, the maximum annual income limit is **$75,300**. You must also be a U.S. resident and have a valid prescription from your doctor. If your insurance covers Aimovig in any meaningful way, you likely will not qualify for this free medication program, though a separate savings card option exists for insured patients. --- ## About Aimovig (Erenumab) Aimovig (erenumab) is a prescription medication approved by the FDA for the preventive treatment of migraine in adults. It belongs to a class of drugs called **CGRP receptor antagonists**, which work by targeting a protein involved in migraine. Aimovig is administered as a monthly self-injection. As a biologic medication, Aimovig carries a high list price — often exceeding $800 per month — making it unaffordable for many patients without insurance coverage or financial assistance. There are currently no FDA-approved biosimilar versions of Aimovig available, which means there is no lower-cost generic equivalent on the market at this time. --- ## Income Eligibility: Full Breakdown The Amgen Safety Net Foundation uses income guidelines set at **500% of the Federal Poverty Level (FPL)** to determine eligibility for Aimovig. The table below shows the maximum annual income allowed based on your household size: | Household Size | Maximum Annual Income | |---|---| | 1 person | $75,300 | | 2 persons | $102,200 | | 3 persons | $129,100 | | 4 persons | $156,000 | If your household has more than four people, the income limit increases with each additional member. Contact the program directly at **(888) 762-6436** to ask about larger household thresholds. Your income is typically verified using your most recent federal tax return, a W-2 form, or three months of recent pay stubs. If your income has changed significantly since your last tax return — for example, due to a job loss — you may be able to submit pay stubs instead to reflect your current situation. If your income is above these limits, you will not automatically qualify for the free medication program. However, you may still have options, which are covered in the final section of this guide. --- ## Insurance Requirements Explained Understanding how your insurance status affects eligibility is important before you apply. - **If you are uninsured:** You are a primary candidate for this program. As long as you meet the income requirements, you can apply for Aimovig at no cost through the Amgen Safety Net Foundation. - **If you have Medicare Part D:** You may still be eligible, but with additional conditions. Medicare Part D patients must meet the income criteria and demonstrate that they are unable to afford their out-of-pocket costs for Aimovig. This exception is not automatic — you will need to provide documentation showing financial hardship. - **If you have private insurance that covers Aimovig poorly or not at all:** If your private insurance does not cover Aimovig, you may qualify. However, if your insurance covers any portion of the drug, you will generally need to demonstrate that the remaining cost is still unaffordable. Contact the program to clarify your specific situation. - **If you have Medicaid:** Medicaid patients are typically not eligible for manufacturer patient assistance programs, since Medicaid is intended to cover medication costs for low-income individuals. If Medicaid is denying coverage for Aimovig, speak with your doctor about an appeal or alternative options. --- ## Step-by-Step: How to Apply Follow these steps to apply for free Aimovig through the Amgen Safety Net Foundation: 1. **Talk to your doctor.** Your physician must be involved in the application. Let them know you plan to apply so they can complete and sign the required portion of the application form. 2. **Gather your documents.** You will need: - A completed application form (with your doctor's signature) - Proof of income — your most recent tax return, W-2, or three months of pay stubs - A valid, current prescription for Aimovig 3. **Choose how to apply.** You have multiple options: - **Online:** Visit [https://www.amgensafetynetfoundation.com/](https://www.amgensafetynetfoundation.com/) to start your application electronically. - **By phone:** Call **(888) 762-6436** to speak with a program representative who can guide you through the process. - **By fax:** Fax your completed paperwork to **(866) 549-7239**. 4. **Submit all documents together.** Incomplete applications will cause delays. Make sure every required document is included before submitting. 5. **Wait for a confirmation.** After submission, the program will review your application. Processing typically takes **7 to 10 business days**. 6. **Follow up if needed.** If you have not heard back after 10 business days, call **(888) 762-6436** to check the status of your application. --- ## What to Expect: Timeline and Delivery After you submit your application, expect a processing time of **7 to 10 business days**. If approved, you will receive confirmation from the Amgen Safety Net Foundation. Aimovig will be **shipped directly to your home address** — you do not need to pick it up at a pharmacy or your doctor's office. You will not need to do anything at the time of delivery beyond receiving the package. Your approval is valid for **one year**. Before that year ends, you will need to reauthorize your enrollment by resubmitting updated income documentation and a renewed application. Watch for notices from the program and plan ahead so you do not experience a gap in your medication supply. --- ## Alternatives If You Don't Qualify If you do not meet the income or insurance requirements for the Amgen Safety Net Foundation, you still have options worth exploring. 1. **Biosimilars:** There are currently no FDA-approved biosimilar versions of Aimovig available. This may change in the future, so ask your doctor to monitor new approvals. 2. **Manufacturer savings card:** If you have private insurance that covers Aimovig, you may be eligible for the **Aimovig savings card**, which can reduce your out-of-pocket costs. Visit [https://www.aimovig.com/paying-for-aimovig](https://www.aimovig.com/paying-for-aimovig) to learn more. 3. **State Pharmaceutical Assistance Programs (SPAPs):** Many states offer programs that help residents pay for prescription drugs, particularly for older adults or people with disabilities. Search your state's health department website for available programs. 4. **NeedyMeds.org:** This free, independent database at [https://www.needymeds.org](https://www.needymeds.org) lists hundreds of patient assistance programs, disease-specific funds, and discount drug options. It is a useful starting point if other programs have not worked out for you. --- > *This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Amgen / Novartis. Program terms may change — verify current requirements at [https://www.aimovig.com/support](https://www.aimovig.com/support) before applying.* ---

Program information last verified: February 27, 2026

Ready to apply for Aimovig assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications